- Report
- August 2026
- 184 Pages
Global
From €3168EUR$3,545USD£2,710GBP
€3520EUR$3,939USD£3,011GBP
- Report
- January 2026
- 193 Pages
Global
From €3168EUR$3,545USD£2,710GBP
€3520EUR$3,939USD£3,011GBP
- Report
- August 2026
- 521 Pages
Global
From €5228EUR$5,850USD£4,472GBP
- Report
- August 2025
- 180 Pages
Global
From €3168EUR$3,545USD£2,710GBP
€3520EUR$3,939USD£3,011GBP
- Training
- January 2024
- 60 Minutes
Global
From €621EUR$695USD£531GBP
Risk Based Monitoring (RBM) is a method of monitoring clinical trials that focuses on identifying and managing risks to the safety of trial participants, data integrity, and trial quality. It is used in the pharmaceutical manufacturing industry to ensure that clinical trials are conducted in accordance with applicable regulations and standards. RBM is a proactive approach to monitoring that uses data analytics to identify potential risks and take corrective action before they become serious. It also helps to ensure that data is collected accurately and that the trial is conducted in a timely manner.
RBM is becoming increasingly popular in the pharmaceutical manufacturing industry as it helps to reduce costs and improve the quality of clinical trials. It also helps to ensure that the data collected is accurate and reliable, which is essential for regulatory approval.
Companies in the Risk Based Monitoring market include Oracle, Medidata Solutions, Parexel, Quintiles, and eClinical Solutions. Show Less Read more